Khiron Life Sciences Corp. (OTCMKTS: KHRNF) has announced that the Colombian government has added low and high THC medical cannabis to the list of compulsory approved...
Khiron Life Sciences Corp (OTCMKTS: KHRNF) has announced financial results for the third quarter ended September 30, 2021. Khiron reports revenue of $3.5 million inQ3 2021...
Khiron Life Sciences Corp (OTCMKTS: KHRNF) has announced the successful completion of its first medical cannabis sale in Brazil. The company plans to leverage its clinical...
Khiron Life Sciences (OTCMKTS:KHRNF) has announced receipt of UK Continuing Professional Development accreditation for its global medical cannabis education platform, Khiron Academy. Khiron partners with Cellen...
Khiron Life Sciences Corp (OTCMKTS:KHRNF) has signed a two-year exclusive accord with Farmacia Universal S.A.C. of Perú to produce and supply medical cannabis products in Lima,...
Khiron Life Sciences Corp (OTCMKTS:KHRNF) has announced that it will be bringing the Kuida CBD brand to Spain. This comes following the receipt of the “no...
Khiron Life Sciences Corp (OTCMKTS:KHRNF) has announced the launch of Aceso Hemp in the Latin American market under a JV with Dixie Brands (USA) Inc (OTCMKTS:DXBRF)....
Khiron Life Sciences Corp (OTCMKTS:KHRNF) has received regulatory nod on June 5, 2019 to take over Uruguay based company NettaGrowth International Inc from TSX Venture Exchange...
Khiron Life Sciences Corp (OTCMKTS:KHRNF) has announced the completion of state-of-the-art facility in Ibague, Colombia. The company made significant strides in commercial registration. It is ready...